Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Nuo Therapeutics Inc
AURX | US
1.34
USD0.08
6.35%
AURX | US
Loading StockChartView...
About Nuo Therapeutics Inc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
12/03/2026
Close
1.34
Open
1.25
High
1.35
Low
1.04
Nuo Therapeutics Inc. a regenerative therapies company develops commercializes and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing in the United States. Its technology separates autologous blood to produce a platelet based therapy for the chronic wound care market. The company was formerly known as Cytomedix Inc. and changed its name to Nuo Therapeutics Inc. in November 2014. Nuo Therapeutics Inc. was incorporated in 1998 and is based in Houston Texas.
View LessAURX | US
Risk
71.1
Sharpe
0
Luna's Score
43/100
Recommendation
Sell
Luna says (AURX | US)
What's Working
Strong Revenue Growth (> 10%)
What's not Working
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Low negative Beta, possible Low Liquidity (< -0.4)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
59.2%1 month
71.1%3 months
102.2%6 months
120.9%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
46.71
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
-67.38
Ent. to rev.
26.91
PEG
-
Other Fundamentals
EBITDA
-2.68M
MarketCap
62.44M
MarketCap(USD)
62.44M
Div. yield
-
Op. margin
-148.58
Erngs. growth
-
Rev. growth
208.70
Ret. on equity
-503.61
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.46
Range1M
0.62
Range3M
1.11
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.50
Price X volume
3.53K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -67.38 | 0.53 | Cheaper |
| Ent. to Revenue | 26.91 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 46.71 | 15.55 | Expensive |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 102.16 | 72.80 | Riskier |
| Debt to Equity | - | -1.23 | - |
| Debt to Assets | - | 0.25 | - |
| Market Cap | 62.44M | 3.66B | Emerging |
